The surgical tradeoffs behind ovarian cancer prevention
Industry Buzz
Ultimately, a straightforward salpingectomy in normal anatomy may add only a few minutes, but individual factors like scar tissue, complex anatomy, or limited surgical visibility may add considerably more time.
—Meghan McGrattan, MD
Feasibility limits such as adhesions or vascular anatomy may prevent complete removal, and I make sure the patient understands that the final decision rests on what can be accomplished safely in the operating room.
—Greg Marchand, MD, FACS, FACOG, FICS
Opportunistic salpingectomy is often described as a minor addition to another operation. But the procedure’s operative burden depends on surgical route, anatomy, technique, and the endpoint selected.[]
How much time does salpingectomy add?
A meta-analysis of 11 cesarean-delivery studies involving 320,443 patients found salpingectomy added a significant 6.3 minutes in cohort studies, and a non-significant 8.1 minutes in RCTs, without higher rates of transfusion, infection, organ injury, readmission, reoperation, or prolonged hospitalization.[]
An early British Columbia population study reported 16 additional minutes during hysterectomy and 10 minutes when salpingectomy replaced tubal ligation.[]
“According to the literature, complete bilateral salpingectomy usually adds between five and fifteen minutes depending on the primary procedure,” says Greg Marchand, MD, FACS, FACOG, FICS, an ABOG-board-certified OB/GYN trained in minimally invasive gynecologic surgery.
Meghan McGrattan, MD, a Royal College–certified OB/GYN and minimally invasive gynecologic surgeon in Toronto, stresses the variation behind those averages. “Ultimately, a straightforward salpingectomy in normal anatomy may add only a few minutes, but individual factors like scar tissue, complex anatomy, or limited surgical visibility may add considerably more time.”
Related: Salpingectomy may cut ovarian cancer risk. So why does it still sound experimental?When can complete removal become unsafe?
The main technical concern is injury to the ovarian vascular supply while dividing the mesosalpinx. Research has led to the following observations:
During cesarean delivery, adhesions and proximity to engorged mesosalpinx vessels prevented bilateral completion in 18.9% of planned cases.[]
Three or more prior cesareans increased the likelihood of requiring an alternative procedure.[]
During vaginal hysterectomy, common reasons for noncompletion included tubes positioned too high in the pelvis and bowel or pelvic-sidewall adhesions.[]
Obesity and previous cesarean delivery have also been linked with greater technical difficulty.
“Dense pelvic adhesions from prior surgery, infection, or endometriosis can make safe isolation of the tubes difficult, especially when they obscure the mesosalpinx or bring the tubes close to the ureters and major vessels,” Dr. Marchand says.
According to ACOG guidance, the plans for salpingectomy should not change the intended hysterectomy route.[] If safe completion requires extensive adhesiolysis, threatens ovarian perfusion, produces significant bleeding, or requires conversion to laparotomy, stopping is appropriate.
“The right outcome is not necessarily two completely removed tubes,” Dr. McGrattan says. “The right outcome is completing the planned operation safely while honoring exactly what the patient consented to.”
However, unilateral removal does not provide permanent contraception and ovarian cancer prevention.
Related: Salpingectomy can reduce ovarian cancer risk—but access remains unevenWhat about ovarian function?
The 2026 ESGO consensus, based on 129 relevant studies, found no demonstrated adverse short-term effect on ovarian function. But long-term evidence remains limited.[]
A 2022 meta-analysis found reassuring preoperative-to-postoperative results but lower AMH and antral follicle counts in some case-control comparisons.[]
A British Columbia cohort of 41,413 patients found no earlier increase in menopause-related visits or hormone-therapy use after salpingectomy.[]
“Overall, the current expert consensus is reassuring,” Dr. McGrattan says. “There is no compelling evidence that salpingectomy causes premature menopause, although a subtle long-term effect cannot yet be definitively excluded.”
Counseling points
Preoperative counseling, therefore, should identify the organs being removed, permanence, need for IVF after bilateral salpingectomy, residual ovarian cancer risk, operative risks, alternatives, and the fallback plan if complete removal proves unsafe.
As Dr. Marchand puts it, “Feasibility limits such as adhesions or vascular anatomy may prevent complete removal, and I make sure the patient understands that the final decision rests on what can be accomplished safely in the operating room.”
Read Next: Will GLP-1–associated weight loss drive demand for abdominoplasty?